Endosomolytic Bioreducible Poly(amido amine disulfide) Polymer Conjugates for the <i>in Vivo</i> Systemic Delivery of siRNA Therapeutics
Rubina Parmar(Alnylam Pharmaceuticals (United States)), Weimin Wang, Eric Kemp, Christopher J. Kochansky, Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Marina Busuek, Bonnie J. Howell(Johns Hopkins University), Eileen S. Walsh(Janssen (Switzerland)), R. M. Garbaccio(United States Military Academy), Brian Carr, Louis S. Crocker, Anthony Leone, Steven L. Colletti(Merck & Co., Inc., Rahway, NJ, USA (United States)), Karen Leander(United States Military Academy)
Cited by 39
Related Papers
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
|Science|1993|2.3k
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409